Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 16,585 | 8,319 | 7,550 | 8,014 | 6,223 |
| Operating Income | -16,585 | -8,319 | -7,550 | -8,014 | -6,223 |
| Interest Expense | 0 | 305 | 82 | 0 | 0 |
| Other Income | 317 | -1,914 | 50 | 118 | 193 |
| Pre-tax Income | -16,268 | -10,538 | -7,582 | -7,896 | -6,031 |
| Net Income Continuous | -16,268 | -10,538 | -7,582 | -7,896 | -6,031 |
| Net Income | $-16,268 | $-10,538 | $-7,582 | $-7,896 | $-6,031 |
| EPS Basic Total Ops | -1.17 | -1.38 | -2.22 | -1.16 | -0.88 |
| EPS Basic Continuous Ops | -1.17 | -1.22 | -2.22 | -1.16 | -0.88 |
| EPS Diluted Total Ops | -1.17 | -1.38 | -2.22 | -1.16 | -0.88 |
| EPS Diluted Continuous Ops | -1.17 | -1.22 | -2.22 | -1.16 | -0.88 |
| EPS Diluted Before Non-Recurring Items | -1.17 | -1.38 | N/A | N/A | N/A |
| EBITDA(a) | $-16,560 | $-8,013 | $-7,371 | $-7,842 | $-6,106 |